Introduction:
Tagrisso 80mg Tablet is a small molecule inhibitor of tyrosine kinase that is used for treating advanced Non-small cell lung cancer (NSCLC) caused due to mutation of Epidermal Growth Factor Receptor EFGR T790M. It is the preferred choice to treat advanced lung cancer that has started spreading to other parts of the body in patients who have failed to respond to other anti-cancer medications.
Uses of Tagrisso 80mg Tablet:
Treatment of Non-Small Cell Lung Cancer (NSCLC).
To treat Advanced Non-Small Cell Lung Cancer, that has spread to other parts of the body that cannot be removed by surgery.
Alternative treatment for patients who have stopped responding to earlier treatments with other tyrosine kinase inhibitors.
How Tagrisso 80mg Tablet works:
Tagrisso 80mg Tablet targets the mutant of tumors that have the gene L858R and exon 19 EFGR. It acts against the abnormal growth of Epidermal Growth Factor Receptor EFGR T790M. It helps to shrink the cancer cells, stops its development and also prevents the lung cancer from relapsing after removal of the tumor by surgery has been done.
Interaction with other drugs:
Inform your doctor about any medications you are taking or have taken before the treatment.
More Information:
Keep the tablets out of sight and reach of children. Store at room temperature. Do not use the medicine if the pack is damaged.
For other medicines and pharmaceutical help checkout MrMed.
Comments